Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Your Daily Pharma Scoop: Advaxis Trial Cleared, Atossa Trial Proceeds, Amgen Resubmits NDA [Seeking Alpha]

Advaxis, Inc. (ADXS) 
Last advaxis, inc. earnings: 9/9 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.advaxis.com
Company Research Source: Seeking Alpha
Summary Stocks in News: ADXS, ATOS FDA lifts clinical hold on Advaxis study of axalimogene filolisbac; shares up 61% premarket Discussion : Advaxis ( ADXS ) announced lifting of hold on its Phase ½ clinical trial of axalimogene filolisbac, in combination with AstraZeneca's Imfinzi (durvalumab). The combination is on trial for the treatment of treatment of advanced, recurrent or refractory cervical cancer and HPV-associated head and neck cancer. Earlier in March FDA halted further trial following the report of death of a patient due to acute respiratory failure after nine months of treatment. The company has implemented fresh FDA guidelines for quicker detection and treatment to avert such events in future. The market responded with a 61% increase in share price on the positive news. Axalimogene filolisbac has orphan drug designation in both the U.S. and E.U. it also received FDA fast track designation. The candidate also received a Special Protocol Assessment for the Show less Read more
Impact Snapshot
Event Time:
ADXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
ADXS alerts

from News Quantified
Opt-in for
ADXS alerts

from News Quantified